PDB Short entry for 4PY4 HEADER TRANSFERASE/TRANSFERASE INHIBITOR 26-MAR-14 4PY4 TITLE CRYSTAL STRUCTURE OF HUMAN POLY(ADP-RIBOSE) POLYMERASE 14, CATALYTIC TITLE 2 DOMAIN IN COMPLEX WITH AN INHIBITOR XL2 COMPND MOL_ID: 1; COMPND 2 MOLECULE: POLY [ADP-RIBOSE] POLYMERASE 14; COMPND 3 CHAIN: A, B; COMPND 4 FRAGMENT: CATALYTIC DOMAIN, UNP RESIDUES 1613-1801; COMPND 5 SYNONYM: PARP-14, ADP-RIBOSYLTRANSFERASE DIPHTHERIA TOXIN-LIKE 8, COMPND 6 ARTD8, B AGGRESSIVE LYMPHOMA PROTEIN 2; COMPND 7 EC: 2.4.2.30; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: PARP14, BAL2, KIAA1268; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET28A KEYWDS ROSSMANN FOLD, CATALYZE THE POST-TRANSLATIONAL MODIFICATION OF KEYWDS 2 PROTEINS, USING B-NAD+, TRANSFERASE-TRANSFERASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR J.LI,Y.XU REVDAT 2 06-DEC-17 4PY4 1 JRNL REVDAT 1 01-APR-15 4PY4 0 JRNL AUTH P.WANG,J.LI,X.JIANG,Z.LIU,N.YE,Y.XU,G.YANG,Y.XU,A.ZHANG JRNL TITL PALLADIUM-CATALYZED N-ARYLATION OF JRNL TITL 2 2-AMINOBENZOTHIAZOLE-4-CARBOXYLATES/CARBOXAMIDES: FACILE JRNL TITL 3 SYNTHESIS OF PARP14 INHIBITORS JRNL REF TETRAHEDRON V. 70 5666 2017 JRNL REFN ISSN 0040-4020 JRNL DOI 10.1016/J.TET.2014.06.064 REMARK 2 REMARK 2 RESOLUTION. 2.76 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.8.1_1168) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : MLHL REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.76 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 39.12 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.110 REMARK 3 COMPLETENESS FOR RANGE (%) : 86.7 REMARK 3 NUMBER OF REFLECTIONS : 18632 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.204 REMARK 3 R VALUE (WORKING SET) : 0.202 REMARK 3 FREE R VALUE : 0.257 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 3.020 REMARK 3 FREE R VALUE TEST SET COUNT : 562 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 39.1272 - 4.3799 0.84 4389 138 0.1860 0.2158 REMARK 3 2 4.3799 - 3.4771 0.86 4478 135 0.1853 0.2666 REMARK 3 3 3.4771 - 3.0378 0.87 4559 145 0.2204 0.2846 REMARK 3 4 3.0378 - 2.7601 0.89 4644 144 0.2530 0.3047 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.300 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 25.070 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 41.90 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 25.08 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.009 2942 REMARK 3 ANGLE : 1.139 3996 REMARK 3 CHIRALITY : 0.077 408 REMARK 3 PLANARITY : 0.005 523 REMARK 3 DIHEDRAL : 14.705 1062 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: THE ENTRY CONTAINS FRIEDEL PAIRS IN REMARK 3 F_PLUS/MINUS COLUMNS REMARK 4 REMARK 4 4PY4 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 07-APR-14. REMARK 100 THE DEPOSITION ID IS D_1000085364. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-MAY-13 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRF REMARK 200 BEAMLINE : BL17U REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97892 REMARK 200 MONOCHROMATOR : SAGITALLY FOCUSED SI(111) REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 315R REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : XDS REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 18644 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.760 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 86.7 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : 0.12000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 7.7300 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.76 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.83 REMARK 200 COMPLETENESS FOR SHELL (%) : 91.9 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: 4F1L REMARK 200 REMARK 200 REMARK: THE ENTRY CONTAINS FRIEDEL PAIRS IN F_PLUS/MINUS COLUMNS REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 50.63 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.49 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 20% PEG3350, 0.2M SODIUM-MALONATE, PH REMARK 280 7.5, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 298K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 22.29000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 72.34000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 33.45500 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 72.34000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 22.29000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 33.45500 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 1340 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 17260 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -3.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 SER A 1700 REMARK 465 TYR A 1701 REMARK 465 ALA A 1702 REMARK 465 GLY A 1703 REMARK 465 LYS A 1704 REMARK 465 ASN A 1705 REMARK 465 ALA A 1706 REMARK 465 VAL A 1707 REMARK 465 ALA A 1708 REMARK 465 TYR A 1709 REMARK 465 GLY A 1751 REMARK 465 ASN A 1752 REMARK 465 HIS A 1753 REMARK 465 SER A 1754 REMARK 465 LEU A 1755 REMARK 465 ILE A 1756 REMARK 465 VAL A 1757 REMARK 465 PRO A 1758 REMARK 465 PRO A 1759 REMARK 465 SER A 1760 REMARK 465 LYS B 1613 REMARK 465 GLN B 1614 REMARK 465 ALA B 1702 REMARK 465 GLY B 1703 REMARK 465 LYS B 1704 REMARK 465 ASN B 1705 REMARK 465 ALA B 1706 REMARK 465 VAL B 1707 REMARK 465 GLN B 1764 REMARK 465 ASN B 1765 REMARK 465 PRO B 1766 REMARK 465 THR B 1767 REMARK 465 ASP B 1768 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 LYS A1613 CG CD CE NZ REMARK 470 TYR B1709 CG CD1 CD2 CE1 CE2 CZ OH REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 PHE B1697 77.31 -102.11 REMARK 500 ARG B1699 -74.42 53.21 REMARK 500 SER B1700 58.53 -60.97 REMARK 500 TYR B1727 -63.64 -107.52 REMARK 500 SER B1754 47.35 -101.99 REMARK 500 LEU B1755 -73.07 -89.47 REMARK 500 ILE B1756 -25.35 73.38 REMARK 500 PRO B1793 62.69 -67.94 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE XL2 A 1901 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE XL2 B 1901 DBREF 4PY4 A 1613 1801 UNP Q460N5 PAR14_HUMAN 1613 1801 DBREF 4PY4 B 1613 1801 UNP Q460N5 PAR14_HUMAN 1613 1801 SEQRES 1 A 189 LYS GLN GLN ASN PHE CYS VAL VAL GLU LEU LEU PRO SER SEQRES 2 A 189 ASP PRO GLU TYR ASN THR VAL ALA SER LYS PHE ASN GLN SEQRES 3 A 189 THR CYS SER HIS PHE ARG ILE GLU LYS ILE GLU ARG ILE SEQRES 4 A 189 GLN ASN PRO ASP LEU TRP ASN SER TYR GLN ALA LYS LYS SEQRES 5 A 189 LYS THR MET ASP ALA LYS ASN GLY GLN THR MET ASN GLU SEQRES 6 A 189 LYS GLN LEU PHE HIS GLY THR ASP ALA GLY SER VAL PRO SEQRES 7 A 189 HIS VAL ASN ARG ASN GLY PHE ASN ARG SER TYR ALA GLY SEQRES 8 A 189 LYS ASN ALA VAL ALA TYR GLY LYS GLY THR TYR PHE ALA SEQRES 9 A 189 VAL ASN ALA ASN TYR SER ALA ASN ASP THR TYR SER ARG SEQRES 10 A 189 PRO ASP ALA ASN GLY ARG LYS HIS VAL TYR TYR VAL ARG SEQRES 11 A 189 VAL LEU THR GLY ILE TYR THR HIS GLY ASN HIS SER LEU SEQRES 12 A 189 ILE VAL PRO PRO SER LYS ASN PRO GLN ASN PRO THR ASP SEQRES 13 A 189 LEU TYR ASP THR VAL THR ASP ASN VAL HIS HIS PRO SER SEQRES 14 A 189 LEU PHE VAL ALA PHE TYR ASP TYR GLN ALA TYR PRO GLU SEQRES 15 A 189 TYR LEU ILE THR PHE ARG LYS SEQRES 1 B 189 LYS GLN GLN ASN PHE CYS VAL VAL GLU LEU LEU PRO SER SEQRES 2 B 189 ASP PRO GLU TYR ASN THR VAL ALA SER LYS PHE ASN GLN SEQRES 3 B 189 THR CYS SER HIS PHE ARG ILE GLU LYS ILE GLU ARG ILE SEQRES 4 B 189 GLN ASN PRO ASP LEU TRP ASN SER TYR GLN ALA LYS LYS SEQRES 5 B 189 LYS THR MET ASP ALA LYS ASN GLY GLN THR MET ASN GLU SEQRES 6 B 189 LYS GLN LEU PHE HIS GLY THR ASP ALA GLY SER VAL PRO SEQRES 7 B 189 HIS VAL ASN ARG ASN GLY PHE ASN ARG SER TYR ALA GLY SEQRES 8 B 189 LYS ASN ALA VAL ALA TYR GLY LYS GLY THR TYR PHE ALA SEQRES 9 B 189 VAL ASN ALA ASN TYR SER ALA ASN ASP THR TYR SER ARG SEQRES 10 B 189 PRO ASP ALA ASN GLY ARG LYS HIS VAL TYR TYR VAL ARG SEQRES 11 B 189 VAL LEU THR GLY ILE TYR THR HIS GLY ASN HIS SER LEU SEQRES 12 B 189 ILE VAL PRO PRO SER LYS ASN PRO GLN ASN PRO THR ASP SEQRES 13 B 189 LEU TYR ASP THR VAL THR ASP ASN VAL HIS HIS PRO SER SEQRES 14 B 189 LEU PHE VAL ALA PHE TYR ASP TYR GLN ALA TYR PRO GLU SEQRES 15 B 189 TYR LEU ILE THR PHE ARG LYS HET XL2 A1901 25 HET XL2 B1901 25 HETNAM XL2 2-({4-[(1R)-1-(DIMETHYLAMINO)ETHYL]PHENYL}AMINO)-6- HETNAM 2 XL2 FLUORO-1,3-BENZOTHIAZOLE-4-CARBOXAMIDE FORMUL 3 XL2 2(C18 H19 F N4 O S) FORMUL 5 HOH *8(H2 O) HELIX 1 1 ASP A 1626 ASN A 1637 1 12 HELIX 2 2 ASN A 1653 ASN A 1671 1 19 HELIX 3 3 ASP A 1685 GLY A 1687 5 3 HELIX 4 4 SER A 1688 GLY A 1696 1 9 HELIX 5 5 ASN A 1718 ALA A 1723 1 6 HELIX 6 6 ASP B 1626 SER B 1641 1 16 HELIX 7 7 ASN B 1653 ASN B 1671 1 19 HELIX 8 8 GLY B 1687 GLY B 1696 1 10 HELIX 9 9 ASN B 1718 ALA B 1723 1 6 SHEET 1 A10 GLU A1677 THR A1684 0 SHEET 2 A10 LYS A1736 LEU A1744 -1 O VAL A1741 N LEU A1680 SHEET 3 A10 ALA A1791 ARG A1800 -1 O PHE A1799 N LYS A1736 SHEET 4 A10 ARG A1644 GLN A1652 -1 N LYS A1647 O THR A1798 SHEET 5 A10 PHE A1617 LEU A1622 -1 N VAL A1620 O ARG A1650 SHEET 6 A10 PHE B1617 GLU B1621 -1 O PHE B1617 N VAL A1619 SHEET 7 A10 ARG B1644 GLN B1652 -1 O ARG B1650 N VAL B1620 SHEET 8 A10 ALA B1791 ARG B1800 -1 O LEU B1796 N GLU B1649 SHEET 9 A10 LYS B1736 LEU B1744 -1 N LYS B1736 O PHE B1799 SHEET 10 A10 GLU B1677 THR B1684 -1 N LEU B1680 O VAL B1741 SHEET 1 B 4 THR A1713 ALA A1716 0 SHEET 2 B 4 LEU A1782 ALA A1785 -1 O ALA A1785 N THR A1713 SHEET 3 B 4 THR A1772 THR A1774 -1 N VAL A1773 O VAL A1784 SHEET 4 B 4 TYR A1748 THR A1749 1 N THR A1749 O THR A1774 SHEET 1 C 4 THR B1713 ALA B1716 0 SHEET 2 C 4 LEU B1782 ALA B1785 -1 O PHE B1783 N PHE B1715 SHEET 3 C 4 THR B1772 THR B1774 -1 N VAL B1773 O VAL B1784 SHEET 4 C 4 TYR B1748 HIS B1750 1 N THR B1749 O THR B1774 SSBOND 1 CYS A 1618 CYS B 1618 1555 1555 2.02 SITE 1 AC1 9 HIS A1682 GLY A1683 TYR A1714 ALA A1716 SITE 2 AC1 9 TYR A1721 SER A1722 TYR A1727 GLN A1764 SITE 3 AC1 9 PRO A1766 SITE 1 AC2 11 SER A1625 HIS B1682 GLY B1683 ASP B1685 SITE 2 AC2 11 TYR B1701 TYR B1714 TYR B1721 SER B1722 SITE 3 AC2 11 THR B1726 TYR B1727 HOH B2003 CRYST1 44.580 66.910 144.680 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.022432 0.000000 0.000000 0.00000 SCALE2 0.000000 0.014945 0.000000 0.00000 SCALE3 0.000000 0.000000 0.006912 0.00000